Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin for prevention of paclitaxel-induced peripheral neuropathy
IRCT20190813044526N1Phase 2Completed
- Sponsor
- Shiraz University of Medical Sciences
- Start
- Sep 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, single-blind trial of metformin in polyneuropathy (2 arms), sponsored by Shiraz University of Medical Sciences. Primary endpoint: Prevention of paclitaxel-induced peripheral neuropathy. Started Sep 2019; status: completed.
02
Drugs
metformin
03
Conditions
polyneuropathy
Beyond the preview
Go deeper on IRCT20190813044526N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20190813044526N1.